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Factors associated with the uptake of
newly introduced childhood vaccinations in
Ethiopia: the cases of rotavirus and
pneumococcal conjugate vaccines
Abrham Wondimu1,4* , Qi Cao2, Jan C. Wilschut3 and Maarten J. Postma2,4,5
Abstract
Background: Childhood immunization programmes have made substantial contributions to lowering the burden
of disease among children in developing countries, however a large proportion of children still remain
unimmunized. This study aimed to explore the determinants of rotavirus vaccine (RVV) and pneumococcal
conjugate vaccine (PCV) uptake in Ethiopia.
Methods: The 2016 Ethiopian demographic and health survey dataset was used in this analysis. A total of 2004
children aged 12–23 months were included in the analysis. A multivariable logistic regression model was employed
to identify the determinants of uptake of the complete schedules of RVV (two doses) and PCV (three doses). Crude
and adjusted odds ratios with 95% confidence intervals (CIs) were calculated.
Results: The uptakes of the complete schedules of RVV and PCV among children aged 12–23 months were 56 and
49.1%, respectively. The likelihood of immunization with the complete schedule of RVV was significantly lower
among children from the relatively poor Afar region in Ethiopia (AOR 0.16; 95%-CI 0.04–0.61). Similarly, children
living in not only the Afar region (AOR 0.10; 95%-CI 0.03–0.38), but also the Gambela region (AOR 0.25; 95%-CI 0.08–
0.83), were less likely to be vaccinated with PCV. On the other hand, children from more wealthy households had
higher odds of vaccination with RVV (AOR 1.69; 95%-CI 1.04–2.75). Also attending antenatal care (ANC) was found
to be significantly associated with uptake of the complete schedule of RVV and PCV.
Conclusions: The uptake of RVV and PCV is suboptimal in Ethiopia. The uptake of the vaccines were found to be
associated with region, ANC use and wealth status.
Keywords: Childhood immunization, Rotavirus vaccine, Pneumococcal conjugate vaccine, Vaccine uptake,
Vaccination status, Ethiopia
Background
Diarrhea and pneumonia are the cause of heavy health
burdens across the world [1, 2]. Globally, in 2011, diarrhea
and pneumonia were respectively responsible for the
death of 0.7 and 1.3 million children under the age of five
[1]. In Ethiopia, diarrhoea and pneumonia are the two
leading causes of morbidity and mortality among children
in this age group [3, 4]. In addition, a considerable eco-
nomic burden was reported in Ethiopia due to the exten-
sive household expenditures of treating diarrhoea or
pneumonia [5]. In the absence of targeted immunization
programmes, rotavirus is associated with 28% of severe
diarrheal cases and Streptococcus pneumoniae is respon-
sible for 18% of cases of severe pneumonia [1].
The effectiveness of rotavirus vaccines (RVVs) and
pneumococcal conjugate vaccines (PCVs) in preventing
gastroenteritis and pneumonia has been established [6, 7].
The World Health Organization (WHO) recommended
the introduction of these vaccines into the immunization
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schedules of developing countries with high background
rates of childhood mortality [8, 9]. Following the recom-
mendation, the Federal Ministry of Health (FMOH) of
Ethiopia introduced into the routine childhood
immunization schedule the 10-valent PCV (PCV10) in
2011 and the RVV in 2013 with financial support from the
GAVI Alliance [10].
The uptake of a vaccine is one of the key perform-
ance indicators of immunization programmes [11].
According to the Global Vaccine Action Plan
(GVAP)—which was endorsed at the 65th World
Health Assembly in May 2012— all countries should
plan to reach 90% national coverage of three doses of
diphtheria-pertussis-tetanus (DTP) vaccines by 2015
and all vaccines in national vaccination programmes
by 2020 [12]. However, the WHO’s report indicated
that global immunization coverage was only at 85% in
2017, and 19.9 million children did not receive rou-
tine life-saving vaccinations in that same year. The re-
port also showed that the coverage level for new and
underused vaccines remains low only 28% for RVV
and 44% for PCV [13].
Despite the government’s improvement measures in
Ethiopia—such as the Reach Every District (RED) ap-
proach and health extension programme—full
immunization coverage in the country remained very
low at 33.3% for all age-appropriate vaccinations, includ-
ing three doses of PCV and two doses of RVV. In
addition, there is marked heterogeneity of the vaccin-
ation coverage across different regions of the country
[10, 14–16]. In Ethiopia, studies that were conducted to
identify factors associated with immunization coverage
among children commonly focused on full immunization
coverage [17–19]. Few studies have also investigated de-
terminants of coverage for specific vaccines included in
the national expanded programme on immunization
(EPI) [20, 21]. So far, however, very little attention has
been paid to newly introduced vaccines such as RVV
and PCV. Therefore, this study aims to investigate the




A secondary analysis of the 2016 Ethiopian Demo-
graphic and Health Survey (EDHS) data was con-
ducted. The EDHS is a population-based cross-
sectional household survey which was conducted in
nine regions (Tigray, Afar, Amhara, Oromiya, Somali,
Benishangul Gumuz, Southern Nations Nationalities
and Peoples (SNNP), Gambela, and Harari) and two
administrative cities (Addis Ababa and Dire Dawa) in
Ethiopia. The detailed study design of the EDHS was
described elsewhere [15].
Sampling technique
The 2016 EDHS employed a stratified sampling
technique to recruit study participants. Each region was
stratified into urban and rural areas, yielding 21
sampling strata. In the first stage, a total of 645 clusters
were selected from urban (202 clusters) and rural (443
clusters) areas with a sampling probability proportional
to the population size. Then households in each of the
selected clusters were listed and used as a sampling
frame for the selection of households. In the second
stage, a fixed number of 28 households in each cluster
were selected by equal probability systematic sampling
in the selected cluster. The final survey was conducted
in 5232 and 11,418 residential households in urban and
rural areas, respectively. All women between 15 and 49
years of age, who were either permanent residents of the
selected households or visitors who stayed in the house-
hold the night before the survey, were eligible to be
interviewed. Accordingly, complete interviews were con-
ducted with 15,683 women, corresponding to a response
rate of about 95% [15].
Data collection
Data on the vaccination status of the children was
collected from the mother’s report and/or vaccination
card (this also includes a booklet or other home-based
record). If the card was available at home or health facil-
ity, information about the vaccination status was directly
obtained from the vaccination card. Otherwise, the
mother was asked to recall all vaccinations received by
their children. According to the 2016 EDHS, data collec-
tors were able to see a vaccination card at home for
34.1% of children aged 12–23 months [15].
Study variables
The vaccination statuses for RVV and PCV for children
aged 12–23months were the outcome variables. Chil-
dren in this age group are expected to have received the
complete schedule of these vaccines, according to the
EPI schedule in Ethiopia (Table 1). The vaccination sta-
tus was considered separately for the two vaccines. A
child who received two doses of RVV and three doses of
Table 1 National EPI schedule by antigens in Ethiopia
Schedule Antigens
Birth BCG, OPV0
6 weeks PENTA1, OPV1, PCV1, RVV1
10 weeks PENTA2, OPV2, PCV2, RVV2
14 weeks PENTA3, OPV3, PCV3, IPV
9 months Measles
EPI Expanded programme on immunization, BCG Baccilus Calmette-Guerin,
OPV Oral Polio Vaccine, PENTA Pentavalent Vaccine (Diptheria-Pertussis-
Tetanus, Hepatitis B Haemophilus Influenzae type B), PCV Pneumococcal
Conjugate Vaccine, RVV Rotavirus Vaccine, IPV: Inactivated Polio Vaccine
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PCV was considered “fully vaccinated” with the respect-
ive vaccines whereas a child who did not receive at least
one dose of the vaccines was categorized as “not (fully)
vaccinated”. The independent variables included in this
study were the following:
 Mother’s characteristics, including age at child birth,
education level, marital status, occupation, religion,
region, residence place, exposure to media (i.e.
access to newspaper, radio and television; those who
had access to any of these three outlets at least once
a week were considered as exposed to media and
others were considered not exposed), use of ANC (≥
4 ANC visits was considered as adequate, whereas
1–3 visits was considered as inadequate [22]), place
of delivery, postnatal check-up and the perception
that the distance to a health facility was a big
problem.
 Partner’s level of education and occupation.
 Child’s characteristics including sex and birth order.
 Household wealth index, a composite measure of
the socioeconomic status of the household used
for ranking the households from poorest to
richest quantiles. It is measured based on assets
ownership and housing characteristics including
a source of drinking water, type of toilet
facilities, type of cooking fuel, materials used for
housing construction, ownership of land, and
other assets.
Analysis
Stata 15.1 was used for data analysis (College Station,
TX: StataCorp LLC). Descriptive statistics were
employed to determine the distribution of independent
variables by vaccination status. A chi-square test was
used to test whether there were associations between
vaccination status and background characteristics.
Bivariate analysis was used to separately evaluate the
effect of each independent variable on the outcome
variable and the variables with a p-value <0.25 in the
bivariate analysis were included in the multivariate
logistic regression models [23]. Child’s sex as a demo-
graphic characteristic was added in the final model
[24]. Variance Inflation Factor (VIF) was employed to
detect the presence of multicollinearity among
independent variables at the cutoff point of 10 [25].
As a result, partner occupation with VIF greater than
10 was omitted from the multivariate logistic regres-
sion models. An F-adjusted mean residual goodness-
of-fit test was utilized to check the goodness-of-fit in
the final model [26]. Due to the survey sample de-
signs employed in DHS, svyset command in Stata 15.1
was used in order to account for inverse probability
weights [15, 27].
Results
In this study, the vaccination status of 2004 Ethiopian
children was assessed. More than half (53.8%) of the
children were female, slightly over one-third (36.6%)
were delivered in health facilities, and 71.8% of all chil-
dren were born within the first five in their birth order.
The vast majority of the children were rural dwellers
(88.4%), and their mothers were between 20 and 34 years
of age (73.2%). Only 8.5% of the children had a mother
who attended secondary or higher education and 45.7%
of the children had a mother who was involved in some
kind of work. In terms of religion, about two-fifths
(39.2%) of the children had a Muslim mother, followed
by Orthodox Christian (34.8%), Protestant (22.2%) or
other (3.8%). Of the children, 25.2, 19.8, 22.4, 18.3, and
14.4% lived in the poorest, poorer, middle, richer, and
richest households, respectively. More than 62% of the
children belonged to mothers who attended at least one
ANC service during their pregnancy (Table 2).
It was found that 56 and 49.1% of the children received
the complete schedule of RVV and PCV, respectively
(Table 2, Additional file 1). Across regions, immunization
coverage with the complete schedule of RVV ranged from
23.3% in Afar to 91.7% in Addis Ababa, and from 17.5% in
Afar to 91.4% in Addis Ababa for PCV (Table 2).
According to bivariate analysis, uptake of RVV and PCV
were associated with various background characteristics
(Table 3). Vaccination of children with complete sched-
ules of RVV and PCV was significantly associated with
educational level, religion, region, wealth quantile, and
working status of the mothers. Similarly, vaccines uptake
were associated with paternal educational and working
status. Moreover, the likelihood of complete schedule up-
take of the vaccines was higher among children of
mothers who received ANC, gave birth in a health facility,
or visited a health facility within 2 months after delivery
for a postnatal check-up. The mother’s exposure to mass
media was also positively associated with the uptake of
RVV and PCV. The uptake of RVV and PCV was higher
in urban areas compared to rural areas and the uptake of
the vaccines was also higher among children of mothers
who do not consider distance to a health facility as a big
problem. The uptake of the complete schedule of both
RVV and PCV did not significantly vary between male
and female children.
Table 3 also shows the results of the multivariate logis-
tic regression. After adjusting for other variables, fac-
tors that remained significant predictors for the
uptake of the complete schedule of RVV and PCV
were region, wealth index and ANC utilization. Ac-
cordingly, as borne out in this analysis, children from
the Afar region were less likely to be fully vaccinated
with RVV (AOR 0.16; 95%-CI 0.04–0.61; p < 0.05)
compared to children in Addis Ababa. Likewise,
Wondimu et al. BMC Public Health         (2019) 19:1656 Page 3 of 10
Table 2 RVV and PCV Immunization status by parental and child characteristics in Ethiopia
Variables Number of Children (%)*, a Fully vaccinated with RVV Fully vaccinated with PCV
n (%)* P-value** n (%)* P-value**
Mother’s age at birth
< 20 84 (4.2) 44 (52.5) 0.639 36 (42.2) 0.328
20–34 1467 (73.2) 836 (57.0) 741 (50.5)
35–49 453 (22.6) 242 (53.4) 208 (45.9)
Mother’s education level
No education 1257 (62.7) 624 (49.6) <0.001 533 (42.4) <0.001
Primary 577 (28.8) 361 (62.7) 329 (57.1)
Secondary and Higher 170 (8.5) 136 (80.1) 122 (71.7)
Religion
Orthodox 697 (34.8) 454 (65.1) <0.001 435 (62.4) <0.001
Protestant 445 (22.2) 258 (57.9) 219 (49.1)
Muslim 786 (39.2) 363 (46.2) 303 (38.5)
Others 76 (3.8) 47 (62.2) 28 (36.5)
Region
Tigray 152 (7.6) 121 (79.8) <0.001 118 (77.7) <0.001
Afar 20 (1) 5 (23.3) 3 (17.5)
Amhara 364 (18.2) 215 (59.1) 220 (60.5)
Oromia 881 (44) 442 (50.2) 337 (38.3)
Somali 76 (3.8) 31 (41.3) 26 (34.9)
Benishangul 21 (1) 16 (76.6) 15 (71.0)
SNNPR 419 (20.9) 229 (54.7) 204 (48.6)
Gambela 5 (0.3) 3 (60.5) 2 (46.1)
Harari 5 (0.2) 3 (61.3) 3 (58.6)
Addis Ababa 52 (2.6) 48 (91.7) 48 (91.4)
Dire Dawa 9 (0.5) 8 (85.3) 7 (75.3)
Wealth index
Poorest 504 (25.2) 220 (43.6) <0.001 181 (36.0) <0.001
Poorer 396(19.8) 201(50.7) 194(48.9)
Middle 450(22.4) 238(53.0) 199(44.2)
Richer 366(18.3) 237(64.6) 205(56.0)
Richest 288(14.4) 226(78.6) 205(71.3)
Marital status
Never in union 16(0.8) 11(70.6) 0.586 8(47.6) 0.143
Married or living with a partner 1897(94.7) 1065(56.2) 944(49.8)
Others 91(4.5) 45(49.6) 32(35.6)
Maternal occupation
Not working 1089(54.3) 576(52.9) 0.043 484(44.5) 0.005
Working 915(45.7) 546 (59.7) 500(54.6)
Sex of child
Male 926(46.2) 505(54.5) 0.444 450(48.6) 0.763
Female 1078(53.8) 617(57.2) 534(49.6)
Birth order
1 372(18.6) 241(64.7) 0.006 205(55.1) 0.020
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children living in Afar or Gambela were 0.10 and
0.25 times less likely to be vaccinated with the
complete schedule of PCV, respectively, compared to
those in Addis Ababa. There appeared to be a trend
that children of mothers from the richer wealth
groups were more likely to be vaccinated. Indeed,
children from the richer wealth quantile were 1,69
times more likely to receive the complete schedule of
RVV (AOR 1.69 95%-CI 1.04–2.75; p = 0.036). For
PCV vaccination, the trend was similar but not statis-
tically significant. The uptake of RVV and PCV was
significantly higher among children born to mothers
who had adequate ANC visits (4 or more than 4
visits) compared to those born to mothers who had
no ANC visit at all (AOR 2.79 95%-CI 1.73–4.51; p <
0.001 and AOR 3.27 95%-CI 2.04–5.23; p < 0.001, re-
spectively). Similarly, mothers with inadequate ANC
visits (less than 4 visits) were also more likely to have
their children vaccinated with the complete schedule
of RVV (AOR 1.64 95%-CI 1.06–2.53; p < 0.001) or
PCV (AOR 2.20 95%-CI 1.43–3.37; p = 0.025) than
those with no ANC visit at all.
Table 2 RVV and PCV Immunization status by parental and child characteristics in Ethiopia (Continued)
Variables Number of Children (%)*, a Fully vaccinated with RVV Fully vaccinated with PCV
n (%)* P-value** n (%)* P-value**
2–5 1063(53) 598(56.3) 540(50.8)
6+ 569(28.4) 282(49.6) 239(42.0)
Exposure to media
Not exposed 1625(81.1) 851(52.4) < 0.001 745(45.8) < 0.001
Exposed 379(18.9) 270(71.3) 239(63.1)
Use of antenatal care
No ANC visit 712(37.4) 283(39.7) < 0.001 204(28.7) < 0.001
Inadequate ANC visit 561(29.4) 322(57.4) 300(53.6)
Adequate ANC visit 632(33.2) 474(74.9) 437(69.2)
Place of delivery
Home 1271(63.4) 615(48.4) < 0.001 506(39.8) < 0.001
Health Facility 733(36.6) 506(69.1) 478(65.3)
Place of Residence
Rural 1772(88.4) 938(52.9) 0.002 815(46.0) < 0.001
Urban 232(11.6) 184(79.1) 169(72.9)
Distance to a health facility
big problem 1201(59.9) 604(50.3) < 0.001 525(43.8) < 0.001
Not a big problem 803(40.1) 518(64.5) 459(57.1)
Postnatal check-up
No 1750(91.8) 956(54.6) < 0.001 836(47.8) 0.003
Yes 155(8.2) 123(78.9) 105(67.8)
Partner’s education level
No education 899(47.6) 448(49.8) < 0.001 382(42.5) < 0.001
Primary 746(39.5) 433(58.1) 397(53.2)
Secondary and Higher 245(12.9) 180(73.7) 161(65.9)
Partner’s occupation
Not working 158(8.4) 62(39.4) 0.011 56(35.2) 0.016
Working 1725(91.6) 993(57.6) 882(51.2)
Number of children aged 0–5 years
< =3 1970(98.3) 1102(55.9) 0.783 967(49.1) 0.862
> 3 34(1.7) 20(58.9) 17(51.1)
Total 2004(100) 1122(56.0) 984(49.1)
*Sampling weights were applied; atotal number varies between categories due to missing values; RVV Rotavirus vaccine, PCV Pneumococcal conjugate vaccine;
**p-value calculated using χ2 analysis
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Table 3 Factors associated with uptake of the complete schedules of RVV and PCV in children aged 12–23 months in Ethiopia,
bivariate and multivariate regression analysis
Variables PCV RVV
COR (95% CI) AOR (95% CI) COR (95% CI) AOR (95% CI)
Mother’s age at birth




No education 1.00 1.00
Primary 1.81(1.32–2.50)** 1.42(0.92–2.22) 1.71(1.26–2.31)* 1.35(0.91–2.00)
Secondary and Higher 3.45(1.72–6.90)** 1.00(0.33–3.05) 4.08(2.11–7.89)** 1.20(0.42–3.42)
Religion
Orthodox 1.00 1.00
Protestant 0.58(0.37–0.90) 0.83(0.47–1.46) 0.74(0.49–1.12) 0.97(0.54–1.76)
Muslim 0.38(0.25–0.56)** 0.68(0.42–1.12) 0.46(0.32–0.66)** 0.71(0.45–1.13)
Others 0.35(0.19–0.64)* 0.64(0.32–1.30) 0.88(0.53–1.48) 1.70(0.92–3.12)
Region
Tigray 0.33(0.13–0.84)* 0.71(0.20–2.55) 0.36(0.14–0.92)* 1.06(0.28–3.99)
Afar 0.02(0.01–0.06)** 0.10(0.03–0.38)* 0.03(0.01–0.08)** 0.16(0.04–0.61)*
Amhara 0.14(0.06–0.35)** 0.59(0.16–2.23) 0.13(0.05–0.32)** 0.59(0.16–2.25)
Oromia 0.06(0.02–0.14)** 0.30(0.08–1.08) 0.09(0.04–0.22)** 0.58(0.16–2.21)
Somali 0.05(0.02–0.13)** 0.37(0.10–1.46) 0.06(0.02–0.16)** 0.58(0.15–2.22)
Benishangul 0.23(0.08–0.65)* 1.07(0.26–4.49) 0.30(0.11–0.77)* 1.86(0.45–7.69)
SNNPR 0.09(0.04–0.22)** 0.31(0.08–1.18) 0.11(0.05–0.26)** 0.45(0.11–1.83)
Gambela 0.08(0.03–0.21)** 0.25(0.08–0.84)* 0.14(0.05–0.36)** 0.45(0.13–1.59)
Harari 0.13(0.05–0.34)** 0.52(0.15–1.79) 0.14(0.05–0.37)** 0.66(0.18–2.43)
Addis Ababa 1.00 1.00
Dire Dawa 0.29(0.10–0.79)* 0.71(0.19–2.61) 0.52(0.19–1.43) 1.94(0.48–7.85)
Wealth index
Poorest 1.00 1.00
Poorer 1.71(1.15–2.54)* 1.32(0.85–2.07) 1.33(0.86–2.06) 1.21(0.76–1.95)
Middle 1.41(0.95–2.10) 0.97(0.61–1.56) 1.46(0.92–2.30) 1.36(0.79–2.33)
Richer 2.27(1.49–3.46)** 1.29(0.76–2.19) 2.36(1.57–3.53)** 1.69(1.04–2.75)*
Richest 4.43(2.46–7.99)** 1.90(0.79–4.54) 4.75(2.52–8.95)** 1.84(0.75–4.50)
Marital status
Never in union 1.00 1.00
Married or living with a partner 1.09(0.30–4.02) 0.53(0.11–2.58)
Others 0.61(0.15–2.48) 0.41(0.08–2.24)
Maternal occupation
Not working 1.00 1.00
Working 1.50(1.13–2.00)* 1.04(0.75–1.44) 1.32(1.01–1.72)* 0.94(0.71–1.26)
Sex of child
Male 1.00 1.00
Female 1.04(0.80–1.37) 0.90(0.66–1.23) 1.12(0.84–1.49) 1.02(0.75–1.40)
Birth order
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Discussion
In developing countries, where the economic and public
health burden of vaccine-preventable disease is substan-
tial, the potential benefit of including new vaccines in
national immunization programmes against diseases not
previously covered by the existing programmes is enor-
mous [28]. Working towards achieving high universal
coverage is also a key issue in order to optimize the ben-
efits of vaccination programmes. Therefore, policy-
makers need to closely monitor vaccination coverage
and take evidence-based measures to stimulate vaccine
uptake and reduce coverage inequalities among different
segments of the population. This study aimed to identify
the factors associated with the uptake of two newly in-
troduced vaccines, RVV and PCV, in Ethiopia.
It was found that 56 and 49.1% of the Ethiopian chil-
dren were vaccinated with the complete schedule of
RVV and PCV, respectively. The slight difference in
coverage between the two vaccines might be attributed
to the difference in the number of doses of the
Table 3 Factors associated with uptake of the complete schedules of RVV and PCV in children aged 12–23 months in Ethiopia,
bivariate and multivariate regression analysis (Continued)
Variables PCV RVV
COR (95% CI) AOR (95% CI) COR (95% CI) AOR (95% CI)
1 1.00 1.00
2–5 0.84(0.59–1.20) 1.26(0.80–2.01) 0.70(0.49–1.00)* 0.83(0.51–1.35)
6+ 0.59(0.40–0.87)* 1.06(0.61–1.84) 0.54(0.37–0.78)* 0.77(0.45–1.33)
Exposure to media
Not exposed 1.00 1.00
Exposed 2.02(1.40–2.93)** 1.19(0.73–1.94) 2.26(1.50–3.42)** 1.38(0.80–2.38)
Use of antenatal care
No ANC visit 1.00 1.00
Inadequate ANC visit 2.87(1.91–4.32)** 2.20(1.43–3.37)** 2.04(1.39–3.01)** 1.64(1.06–2.53)*
Adequate ANC visit 5.59(3.77–8.30)** 3.27(2.04–5.23)** 4.54(3.05–6.74)** 2.79(1.73–4.51)**
Place of delivery
Home 1.00 1.00
Health Facility 2.84(2.08–3.88)** 1.41(0.97–2.06) 2.39(1.76–3.24)* 1.11(0.74–1.67)
Place of Residence
Rural 1.00 1.00
Urban 3.16(1.71–5.83)** 1.03(0.44–2.42) 3.36(1.54–7.34)* 1.29(0.40–4.18)
Distance to a health facility
Big problem 1.00 1.00
Not a big problem 1.71(1.30–2.25)** 0.92(0.66–1.28) 1.80(1.33–2.43) 1.14(0.80–1.63)
Postnatal check-up
No 1.00 1.00
Yes 2.30(1.32–4.00)* 1.01(0.56–1.81) 3.11(1.65–5.86)** 1.69(0.84–3.40)
Partner education
No education 1.00 1.00
Up to primary 1.54(1.14–2.08)* 1.31(0.88–1.95) 1.40(1.02–1.91)* 1.00(0.67–1.49)
Secondary and higher 2.61(1.63–4.18)** 0.91(0.44–1.87) 2.82(1.72–4.61)** 0.82(0.38–1.75)
Partner occupation£
Not working 1.00 1.00
Working 1.93(1.12–3.32)* 2.09(1.17–3.72)*
Number of children aged 0–5 years
< =3 1.00 1.00
> 3 1.09(0.43–2.75) 1.13(0.47–2.71)
RVV Rotavirus vaccine, PCV Pneumococcal conjugate vaccine, COR Crude odds ratio, AOR Adjusted odds ratio, CI Confidence Interval **P < 0.001), *p < 0.05, £: not
included in the multivariate regression analysis due to collinearity
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vaccines—2 for RVV versus 3 for PCV. Compared to the
two-dose RVV, there is a higher possibility of dropout
for the three-dose PCV [29]. Slight differences in cover-
age between the two vaccines have also been noted else-
where [30]. According to the EDHS report, the coverage
also varies between other vaccines included in the rou-
tine EPI schedule in Ethiopia [15]. The observed cover-
age of the two vaccines in Ethiopia is far below the
target (>90%) set by the country [10].
There are several factors that can predict childhood
immunization coverage [31]. In our analysis, we identi-
fied that administrative regions, wealth status, and ANC
visits were significantly associated with uptake of the
complete schedule of RVV and PCV. With regard to ad-
ministrative regions, children in the Afar or Gambela re-
gions were less likely to be (fully) vaccinated with RVV
or PCV. Likewise, children who live in Afar or Gambela
were also less likely to receive the complete schedule of
PCV. In Afar and Gambela, significant proportions of
the population are pastoralists, commonly moving from
one place to another in search of food and water, which
makes the provision of health care services challenging
including childhood immunization. Moreover, as emer-
ging/developing regions, Afar and Gambela are charac-
terized by fragile health care systems often with poor
organization and inadequate infrastructure compared to
other regions in the country. This makes it even more
difficult to provide vaccination services. Regional vari-
ation of immunization coverage within a country has
also been documented in several studies from other
developing countries [18, 24, 30, 32–34].
Wealth-based health inequality is a major impediment
for the realization of universal health-care coverage. In
this study, children from the richer wealth quantile were
more likely to receive the complete schedule of RVV.
Although childhood immunization by itself is free of
charge in Ethiopia, there is nevertheless a heavy eco-
nomic burden associated with childhood vaccination due
to travel costs and forgone income because of work loss
while seeking immunization services for the children.
This finding is in concordance with that in other previ-
ous studies [32, 33, 35, 36].
As noted previously [19, 24, 33, 37–39], our study
showed that childhood vaccination with RVV and PCV
was found to be significantly associated with ANC service
utilization. The odds of vaccination with complete sched-
ule RVV and PCV were 2.8 and 3.3 times higher for chil-
dren whose mothers received adequate ANC (≥4 visit)
and 1.6 and 2.2 times higher for children whose mothers
received inadequate ANC (< 4 visit), compared to those
whose mothers had not made any ANC visit at all. This
may be explained by the fact that ANC visits might have
improved the mothers’ knowledge and attitude towards
the importance of childhood vaccination. In addition,
prior experience and interaction during ANC might build
trust towards vaccination services, which is important for
reducing the vaccine confidence gap in the community.
The strength of the current study is that it is based on
nationwide data. However, there are several limitations
as well. Firstly, since mothers’ self-report is used as a
source of information for the child’s immunization
status, there is a possibility of recall bias. However, a
study in Tanzania documented a high accuracy and min-
imal bias due to parental recall during estimation of vac-
cination coverage compared to card-based data [40].
Secondly, in our study, we focused mainly on the de-
mand side of the determinants and did not assess the ef-
fect of the supply side on the uptake of vaccines,
because these data are lacking in the EDHS. Clearly, vac-
cine supply will also have a significant effect on
immunization coverage. Lastly, the current study is fo-
cusing only on vaccines newly introduced to the country.
Despite this limitation, the findings of this study will
provide transferable lessons for other vaccine programs
within Ethiopia especially for those having the same
schedule with vaccines under consideration in our study.
Conclusions
The overall coverage of RVV and PCV among children
between 12 and 23months of age was suboptimal and
below the national target in Ethiopia. Regional variation,
wealth status and utilization of ANC were found to be
significant predictors for the uptake of the vaccines. Vac-
cination coverage among children from the Afar and
Gambela regions, as well as among those from the poor-
est sections of the population, was found to be minimal.
Hence, this study emphasizes the need for specific inter-
ventions, that take regional and wealth status differences
into consideration, in order to improve childhood
vaccination coverage in the country. Policy makers
might consider expanding ANC service utilization
among mothers as a potential strategy to improve child-
hood immunization coverage in Ethiopia.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12889-019-8002-8.
Additional file 1: Figure S1. Percentage* of children aged 12–23
months who are fully vaccinated with RVV and PCV in Ethiopia, by a
source of information (Vaccination card‡ seen at home, Vaccination
record at health facility†, Mother’s report and Any source), Ethiopia DHS
2016.
Abbreviations
AOR: Adjusted odds ratio; CIs: Confidence intervals; COR: Crude odds ratio;
DTP: Diphtheria-pertussis-tetanus; EDHS: Ethiopian Demographic and Health
Survey; EPI: Expanded programme on immunization; GVAP: Global Vaccine
Action Plan; PCV: Pneumococcal conjugate vaccine; RED: Reach Every District;
RVV: Rotavirus vaccine; SNNP: Southern Nations Nationalities and Peoples;
WHO: World Health Organization
Wondimu et al. BMC Public Health         (2019) 19:1656 Page 8 of 10
Acknowledgments
The authors would like to thank Measure DHS programme for granting
permission to use the data.
Authors’ contributions
AW designed the study in consultation with MJP, analyzed the data and
drafted the manuscript. QC was involved in the data analysis and revised the
manuscript. MJP and JCW interpreted the data and critically revised the
manuscript. All authors have approved the final version of the paper.
Funding
AW’s Ph.D. project is funded by the Netherlands Organization for
International Cooperation in Higher Education (NUFFIC) and this study is part
of his Ph.D. project.
Availability of data and materials
Ethiopia Demographic and Health Survey 2016 data was used in this study; it
is available for public use upon registration and request to DHS program at
https://dhsprogram.com/
Ethics approval and consent to participate
The 2016 EDHS data is available for public use by request from the Measure
Demographic and Health Survey (Measure DHS) website (https://
dhsprogram.com). Permission to use the data was obtained from the




Prof Postma reports grants and honoraria from various pharmaceutical
companies, including those developing, producing and marketing rotavirus
and pneumococcal vaccines.
Author details
1Department of Pharmaceutics, School of Pharmacy, College of Medicine
and Health Sciences, University of Gondar, Gondar, Ethiopia. 2Unit of
PharmacoTherapy, Epidemiology & Economics (PTE2), Department of
Pharmacy, University of Groningen, Groningen, The Netherlands.
3Department of Medical Microbiology, University Medical Center Groningen
(UMCG), University of Groningen, Groningen, The Netherlands. 4Department
of Health Sciences, University Medical Center Groningen (UMCG), University
of Groningen, Groningen, The Netherlands. 5Department of Economics,
Econometrics & Finance, Faculty of Economics & Business, University of
Groningen, Groningen, The Netherlands.
Received: 18 February 2019 Accepted: 25 November 2019
References
1. Walker CLF, Rudan I, Liu L, Nair H, Theodoratou E, Bhutta ZA, et al. Global
burden of childhood pneumonia and diarrhoea. Lancet. 2013;381(9875):
1405–16.
2. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and
national life expectancy, all-cause mortality, and cause-specific mortality for
249 causes of death, 1980–2015: a systematic analysis for the Global Burden
of Disease Study 2015. Lancet. 2016;388(10053):1459–544.
3. Deribew A, Tessema GA, Deribe K, Melaku YA, Lakew Y, Amare AT, et al.
Trends, causes, and risk factors of mortality among children under 5 in
Ethiopia, 1990–2013: findings from the global burden of disease study 2013.
Popul Health Metrics. 2016;14(1):42.
4. UNICEF. Committing to Child Survival: A Promise Renewed Progress Report.
New York; 2014. Cited 2019 Jan 11]. Available from: http://files.unicef.org/
publications/files/APR_2014_web_15Sept14.pdf
5. Memirie ST, Metaferia ZS, OF N, Levin CE, Verguet S, Johansson KA.
Household expenditures on pneumonia and diarrhoea treatment in
Ethiopia: a facility-based study. BMJ Glob Health. 2017;2(1):e000166.
6. Soares-Weiser K, Maclehose H, Bergman H, Ben-Aharon I, Nagpal S,
Goldberg E, et al. Vaccines for preventing rotavirus diarrhoea: vaccines in
use. Cochrane Database Syst Rev. 2012;11:CD008521.
7. Ewald H, Briel M, Vuichard D, Kreutle V, Zhydkov A, Gloy V. The Clinical
Effectiveness of Pneumococcal Conjugate Vaccines: A Systematic Review and
Meta-analysis of Randomized Controlled Trials. Dtsch Aerzteblatt Online. 2016;
Available from: https://www.aerzteblatt.de/10.3238/arztebl.2016.0139
8. World Health Organization. Rotavirus vaccines WHO position paper: January
2013 – recommendations. Vaccine. 2013;31(52):6170–1.
9. Publication WHO. Pneumococcal vaccines WHO position paper – 2012 –
Recommendations. Vaccine. 2012;30(32):4717–8.
10. EFMoH. Ethiopia National Expanded Program on Immunization,
Comprehensive Multi - Year Plan 2016–2020. Addis Ababa: Federal Ministry
of Health; 2015.
11. World Health Organization. WHO | Strategic indicators. WHO. World Health
Organization; 2014 [Cited 2019 Jan 11]. Available from: https://www.who.
int/immunization/monitoring_surveillance/routine/indicators/en/
12. World Health Organization. Global Vaccine Action Plan. 2013.
13. WHO. Immunization coverage. [Cited 2019 Jan 11]. Available from: https://
www.who.int/news-room/fact-sheets/detail/immunization-coverage
14. Wondwossen L, Gallagher K, Braka F, Karengera T. Advances in the control
of vaccine preventable diseases in Ethiopia. Pan Afr Med J. 2017;27:1.
15. Central Statistical Agency (CSA) [Ethiopia] and ICF. Ethiopia Demographic
and Health Survey 2016. Addis Ababa, Ethiopia, and Rockville, Maryland,
USA: CSA and ICF; 2016.
16. Belete H, Kidane T, Bisrat F, Molla M, Mounier-Jack S, Kitaw Y. Routine
immunization in Ethiopia. J Heal Dev. 2015;1:2–7.
17. Regassa N, Bird Y, Moraros J. Preference in the use of full childhood
immunizations in Ethiopia: the role of maternal health services. Patient
Prefer Adherence. 2019;13:91–9.
18. Lakew Y, Bekele A, Biadgilign S. Factors influencing full immunization
coverage among 12–23 months of age children in Ethiopia: evidence from
the national demographic and health survey in 2011. BMC Public Health.
2015;15(1):728.
19. Etana B, Deressa W. Factors associated with complete immunization
coverage in children aged 12–23 months in ambo Woreda, Central Ethiopia.
BMC Public Health. 2012;12(1):566.
20. Tsehay AK, Worku GT, Alemu YM. Determinants of BCG vaccination
coverage in Ethiopia: A cross-sectional survey. BMJ Open. 2019;9(2).
21. Geremew TT, Gezie LD, Abejie AN. Geographical variation and associated
factors of childhood measles vaccination in Ethiopia: a spatial and multilevel
analysis. BMC Public Health. 2019;19:1.
22. World Health Organization. WHO antenatal care randomized trial: manual
for the implementation of the new model. Geneva: World Health
Organization. Geneva; 2002.
23. Hosmer DW, Lemeshow S, Sturdivant RX. Applied logistic regression. 3rd ed.
Hoboken: Wiley; 2013.
24. Mbengue MAS, Sarr M, Faye A, Badiane O, Camara FBN, Mboup S, et al.
Determinants of complete immunization among senegalese children aged
12-23 months: evidence from the demographic and health survey. BMC
Public Health. 2017;17(1):630.
25. Hair JF, Black WC, Babin BJ, Anderson RE. Multivariate Data Analysis. 7th ed.
Edinburgh Gate, Harlow, Essex: Pearson Education Limited; 2014.
26. Archer KJ, Lemeshow S. Goodness-of-fit test for a logistic regression model
fitted using survey sample data. Stata J. 2006;6(1):97–105.
27. Croft TN, Marshall AMJ, Allen CK, et al. Guide to DHS Statistics. Rockville,
Maryland, USA: ICF; 2018.
28. Greenwood B. The contribution of vaccination to global health: past,
present and future. Philos Trans R Soc Lond Ser B Biol Sci. 2014;369(1645):
20130433.
29. Baguune B, Ndago JA, Adokiya MN. Immunization dropout rate and data
quality among children 12–23 months of age in Ghana. Arch Public Heal.
2017;75(1):18.
30. Ntenda PAM, Mwenyenkulu ET, Putthanachote N, Nkoka O, Mhone TG,
Motsa MPS, et al. Predictors of uptake of newly introduced vaccines in
Malawi - monovalent human rotavirus and pneumococcal conjugate
vaccines: evidence from the 2015-16 Malawi demographic and health
survey. J Trop Pediatr. 2019;65(3):287–96.
31. Phillips DE, Dieleman JL, Lim SS, Shearer J. Determinants of effective vaccine
coverage in low and middle-income countries: a systematic review and
interpretive synthesis. BMC Health Serv Res. 2017;17(1):681.
32. Sheikh N, Sultana M, Ali N, Akram R, Mahumud R, Asaduzzaman M, et al.
Coverage, timelines, and determinants of incomplete immunization in
Bangladesh. Trop Med Infect Dis. 2018;3(3):72.
Wondimu et al. BMC Public Health         (2019) 19:1656 Page 9 of 10
33. Herliana P, Douiri A. Determinants of immunisation coverage of children
aged 12–59 months in Indonesia: a cross-sectional study. BMJ Open.
2017;7(12):e015790.
34. Bugvi AS, Rahat R, Zakar R, Zakar MZ, Fischer F, Nasrullah M, et al. Factors
associated with non-utilization of child immunization in Pakistan: Evidence
from the Demographic and Health Survey 2006–07. BMC Public Health.
2014;14:232.
35. Devasenapathy N, Ghosh Jerath S, Sharma S, Allen E, Shankar AH, Zodpey S.
Determinants of childhood immunisation coverage in urban poor
settlements of Delhi, India: a cross-sectional study. BMJ Open.
2016;6(8):e013015.
36. Rahman M, Obaida-Nasrin S. Factors affecting acceptance of complete
immunization coverage of children under five years in rural Bangladesh.
Salud Publica Mex. 2010;52(2):134–40.
37. Adedokun ST, Uthman OA, Adekanmbi VT, Wiysonge CS. Incomplete
childhood immunization in Nigeria: a multilevel analysis of individual and
contextual factors. BMC Public Health. 2017;17(1):236.
38. Hemat S, Takano T, Kizuki M, Mashal T. Health-care provision factors
associated with child immunization coverage in a city centre and a rural
area in Kabul, Afghanistan. Vaccine. 2009;27(21):2823–9.
39. Bondy JN, Thind A, Koval JJ, Speechley KN. Identifying the determinants of
childhood immunization in the Philippines. Vaccine. 2009;27(1):169–75.
40. Binyaruka P, Borghi J. Validity of parental recalls to estimate vaccination
coverage: evidence from Tanzania. BMC Health Serv Res. 2018;18(1):440.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Wondimu et al. BMC Public Health         (2019) 19:1656 Page 10 of 10
